Legend Biotech Corporation (FRA:9LB)
Germany flag Germany · Delayed Price · Currency is EUR
23.80
-0.20 (-0.83%)
At close: Nov 28, 2025

Legend Biotech Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Nov '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
4,2645,7669,8967,8196,3093,053
Upgrade
Market Cap Growth
-38.62%-41.73%26.55%23.93%106.63%-
Upgrade
Enterprise Value
3,7634,9308,8987,2005,8152,586
Upgrade
Last Close Price
23.0031.6054.0046.4041.6023.40
Upgrade
PS Ratio
5.509.5238.3671.42104.2649.80
Upgrade
PB Ratio
4.955.748.7411.239.376.25
Upgrade
P/TBV Ratio
4.955.758.7711.289.436.28
Upgrade
EV/Sales Ratio
4.818.1434.4965.7696.0842.17
Upgrade
Debt / Equity Ratio
0.410.340.260.380.160.01
Upgrade
Asset Turnover
0.530.360.180.100.080.15
Upgrade
Inventory Turnover
29.4529.9135.3566.27176.58157.02
Upgrade
Quick Ratio
2.764.496.773.594.115.09
Upgrade
Current Ratio
2.874.626.923.694.145.14
Upgrade
Return on Equity (ROE)
-22.54%-15.45%-51.94%-59.11%-59.19%-71.12%
Upgrade
Return on Assets (ROA)
-6.92%-10.84%-17.39%-23.37%-26.75%-28.32%
Upgrade
Return on Capital (ROIC)
-8.27%-12.84%-21.19%-29.86%-33.05%-37.86%
Upgrade
Return on Capital Employed (ROCE)
-14.90%-21.90%-27.10%-44.30%-44.30%-37.90%
Upgrade
Earnings Yield
-4.79%-2.97%-4.74%-5.34%-5.62%-7.13%
Upgrade
FCF Yield
-3.77%-2.65%-3.78%-2.66%-3.35%-6.67%
Upgrade
Buyback Yield / Dilution
-0.86%-3.84%-10.71%-12.91%-19.21%-18.15%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.